Hemp Supplement Sales Continue In US Without FDA Acknowledgement As Lawful Products
Executive Summary
Decision, explained by Principal Deputy Commissioner Woodcock, turns page on FDA’s 2019 announcement, after hemp was de-scheduled in 2018 farm bill, it would consider rulemaking for lawful use of hemp in supplements.
You may also be interested in...
Industry Groups Put It In Writing: House Hearing Needed On FDA Hemp 'Regulation, Or Lack Thereof'
Hemp, supplement industry groups say Energy and Commerce hearing is needed on FDA’s “regulation, or lack thereof, of the rapidly growing hemp market.”
Congress Hearing Chorus Of Trade Groups’ Concerns About FDA’s Hemp Regulatory Conundrum
AHPA, CHPA and UNPA say “current statutory definitions already apply to hemp and its extracts and naturally occurring constituents” and “there is no need for a new regulatory pathway to include these ingredients in dietary supplements.” CRN and USHR also assert FDA currently has regulatory tools to allow hemp ingredients’ use in food and supplements.
US Hemp Supplement Market Could Go Up In Smoke, Cast Cloud On Cannabis Without Regulation
Market's direction depends on different influences, according to witnesses testifying at recent House hearing looking at FDA’s position on using hemp ingredients in food and dietary supplements. Rising costs and plummeting prices hit marketers as acreage for hemp and amount harvested shrink.